Literature DB >> 15054643

Generalized atherosclerosis sparing the transplanted kidney in Schimke disease.

Thomas Lücke1, Katja M Marwedel, Nele K Kanzelmeyer, Akira Hori, Gisela Offner, Hans-Heinrich Kreipe, Jochen H H Ehrich, Anibh M Das.   

Abstract

Schimke-immuno-osseous dysplasia (SIOD) is a multisystem disorder caused by a mutation of the chromatin remodeling protein. The main clinical findings are spondyloepiphyseal dysplasia with disproportional growth deficiency, nephrotic syndrome with focal and segmental glomerulosclerosis, and defective cellular immunity. Transitory ischemic attacks due to vaso-occlusive processes are still an untreatable and life-limiting complication in patients with SIOD. The underlying pathophysiology of vaso-occlusive processes in SIOD is unclear. We report the clinical and pathological findings of the eldest published patient with the severe form of SIOD, who died at the age of 23 years due to pulmonary hypertension with subsequent right heart failure. The autopsy revealed a severe generalized atherosclerosis including the brain, heart, and pulmonary arteries. However, the kidney that was transplanted at the age of 5 years showed a good graft function without glomerular sclerosis and with only minimal nephrosclerosis on histology. Thus, the absence of severe vaso-occlusive processes in the transplanted organ and in the severely atherosclerotic host may indicate that the vaso-occlusive processes in SIOD are not caused by post-transplant cardiovascular morbidity such as arterial hypertension and hyperlipidemia. Instead, vascular factors of the host such as endothelial dysfunction may explain the pathophysiology of atherosclerosis in SIOD.

Entities:  

Mesh:

Year:  2004        PMID: 15054643     DOI: 10.1007/s00467-004-1426-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  22 in total

1.  Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature.

Authors:  C F Boerkoel; S O'Neill; J L André; P J Benke; R Bogdanovíć; M Bulla; A Burguet; S Cockfield; I Cordeiro; J H Ehrich; S Fründ; D F Geary; A Ieshima; F Illies; M W Joseph; I Kaitila; G Lama; B Leheup; M D Ludman; D R McLeod; A Medeira; D V Milford; T Ormälä; Z Rener-Primec; A Santava; H G Santos; B Schmidt; G C Smith; J Spranger; N Zupancic; R Weksberg
Journal:  Eur J Pediatr       Date:  2000 Jan-Feb       Impact factor: 3.183

2.  Schimke immuno-osseous dysplasia.

Authors:  D M Gilchrist; F L Harley
Journal:  J Pediatr       Date:  1992-03       Impact factor: 4.406

3.  Schimke immuno-osseous dysplasia: a newly recognized multisystem disease.

Authors:  J Spranger; G K Hinkel; H Stöss; W Thoenes; D Wargowski; F Zepp
Journal:  J Pediatr       Date:  1991-07       Impact factor: 4.406

4.  Autoimmune enteropathy in Schimke immunoosseous dysplasia.

Authors:  I Kaitila; E Savilahti; T Ormälä
Journal:  Am J Med Genet       Date:  1998-06-05

5.  Chondroitin-6-sulphaturia, defective cellular immunity, and nephrotic syndrome.

Authors:  R N Schimke; W A Horton; C R King
Journal:  Lancet       Date:  1971-11-13       Impact factor: 79.321

6.  Chondroitin-6-sulfate mucopoly-saccharidosis in conjunction with lymphopenia, defective cellular immunity and the nephrotic syndrome.

Authors:  R N Schimke; W A Horton; C R King; N L Martin
Journal:  Birth Defects Orig Artic Ser       Date:  1974

7.  Clinical quiz. Schimke immunoosseous dysplasia syndrome (SIOD).

Authors:  F Rodrigo; J Ferrer-Cañabate; S Gracia; I Tovar; E Borrajo; C Tellez; P Martínez
Journal:  Pediatr Nephrol       Date:  2001-07       Impact factor: 3.714

8.  Predictors of stroke in patients receiving chronic hemodialysis.

Authors:  K Iseki; K Fukiyama
Journal:  Kidney Int       Date:  1996-11       Impact factor: 10.612

9.  Plasma lipids, lipoproteins and apolipoproteins AI, AII, and B in renal transplanted children: what risk for accelerated atherosclerosis?

Authors:  S Goldstein; G Duhamel; M H Laudat; M Berthelier; C Hervy; M J Tete; M Broyer
Journal:  Nephron       Date:  1984       Impact factor: 2.847

10.  Schimke immunoosseous dysplasia complicated by moyamoya phenomenon.

Authors:  C F Boerkoel; M J Nowaczyk; S I Blaser; W S Meschino; R Weksberg
Journal:  Am J Med Genet       Date:  1998-06-30
View more
  12 in total

1.  Report of an NIH task force on research priorities in chronic kidney disease in children.

Authors:  Russell W Chesney; Eileen Brewer; Marva Moxey-Mims; Sandra Watkins; Susan L Furth; William E Harmon; Richard N Fine; Ronald J Portman; Bradley A Warady; Isidro B Salusky; Craig B Langman; Debbie Gipson; Peter Scheidt; Harold Feldman; Frederick J Kaskel; Norman J Siegel
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

2.  An unusual cause of nephrotic syndrome: Answers.

Authors:  Zeynep Yuruk Yildirim; Melis Ozkan; Alev Yilmaz; Hülya Kayserili; Cemile Pehlivanoglu; Sevinc Emre; Ahmet Nayir
Journal:  Pediatr Nephrol       Date:  2018-11-07       Impact factor: 3.714

3.  Membranous nephropathy in Schimke immuno-osseous dysplasia.

Authors:  Nihal Ozdemir; Harika Alpay; Abdullah Bereket; Gamze Bereket; Neşe Biyikli; Metin Aydoğan; Fulya Cakalağoğlu; Işin Kiliçaslan; Ihsan Akpinar
Journal:  Pediatr Nephrol       Date:  2006-03-29       Impact factor: 3.714

4.  Mitochondrial function in schimke-immunoosseous dysplasia.

Authors:  Thomas Lücke; Jochen H H Ehrich; Anibh M Das
Journal:  Metab Brain Dis       Date:  2005-09       Impact factor: 3.584

5.  Dental abnormalities in Schimke immuno-osseous dysplasia.

Authors:  M Morimoto; O Kérourédan; M Gendronneau; C Shuen; A Baradaran-Heravi; Y Asakura; M Basiratnia; R Bogdanovic; D Bonneau; A Buck; J Charrow; P Cochat; K A Dehaai; M S Fenkçi; P Frange; S Fründ; H Fryssira; K Keller; S Kirmani; C Kobelka; K Kohler; D B Lewis; L Massella; D R McLeod; D V Milford; F Nobili; A H Olney; C N Semerci; N Stajic; A Stein; S Taque; J Zonana; T Lücke; G Hendson; M Bonnaure-Mallet; C F Boerkoel
Journal:  J Dent Res       Date:  2012-07       Impact factor: 6.116

6.  Schimke immuno-osseous dysplasia: a clinicopathological correlation.

Authors:  J Marietta Clewing; Barbara C Antalfy; Thomas Lücke; Behzad Najafian; Katja M Marwedel; Akira Hori; Ralph M Powel; A F Safo Do; Lydia Najera; Karen SantaCruz; M John Hicks; Dawna L Armstrong; Corndins F Boerkoel
Journal:  J Med Genet       Date:  2006-07-13       Impact factor: 6.318

7.  R561C missense mutation in the SMARCAL1 gene associated with mild Schimke immuno-osseous dysplasia.

Authors:  Arend Bökenkamp; Miranda deJong; Joanna A E van Wijk; Diana Block; Johanna M van Hagen; Michael Ludwig
Journal:  Pediatr Nephrol       Date:  2005-10-20       Impact factor: 3.714

8.  Dental abnormalities and preventive oral care in Schimke immuno-osseous dysplasia.

Authors:  M Gendronneau; O Kérourédan; S Taque; J L Sixou; M Bonnaure-Mallet
Journal:  Eur Arch Paediatr Dent       Date:  2013-12-11

9.  Novel SMARCAL1 bi-allelic mutations associated with a chromosomal breakage phenotype in a severe SIOD patient.

Authors:  Amos J Simon; Atar Lev; Marta Jeison; Zvi U Borochowitz; David Korn; Yaniv Lerenthal; Raz Somech
Journal:  J Clin Immunol       Date:  2013-11-07       Impact factor: 8.317

10.  Reduced elastogenesis: a clue to the arteriosclerosis and emphysematous changes in Schimke immuno-osseous dysplasia?

Authors:  Marie Morimoto; Zhongxin Yu; Peter Stenzel; J Marietta Clewing; Behzad Najafian; Christy Mayfield; Glenda Hendson; Justin G Weinkauf; Andrew K Gormley; David M Parham; Umakumaran Ponniah; Jean-Luc André; Yumi Asakura; Mitra Basiratnia; Radovan Bogdanović; Arend Bokenkamp; Dominique Bonneau; Anna Buck; Joel Charrow; Pierre Cochat; Isabel Cordeiro; Georges Deschenes; M Semin Fenkçi; Pierre Frange; Stefan Fründ; Helen Fryssira; Encarna Guillen-Navarro; Kory Keller; Salman Kirmani; Christine Kobelka; Petra Lamfers; Elena Levtchenko; David B Lewis; Laura Massella; D Ross McLeod; David V Milford; François Nobili; Jorge M Saraiva; C Nur Semerci; Lawrence Shoemaker; Nataša Stajić; Anja Stein; Doris Taha; Dorothea Wand; Jonathan Zonana; Thomas Lücke; Cornelius F Boerkoel
Journal:  Orphanet J Rare Dis       Date:  2012-09-22       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.